AKT1 and neoplasm: In this context, the current study aimed to synthesize and characterize a nanoconjugate based on SWCNT-COOH and CDDP and to investigate its in vitro anti-tumor potential by analyzing the efficiency of its inhibition of the PI3K/Akt signaling pathway and the motility of TNBC cells.